JASMINE JOSEPH: Open Payments
NPI 1205397635 · SOUTH ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,813 in 164 payments from 28 companies in 2025. Trend: 2023 $1,226 · 2024 $2,009 · 2025 $2,813
Food & beverage: $2,813
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $513 |
| Teva Pharmaceuticals USA, Inc. | 12 | $334 |
| Novartis Pharmaceuticals Corporation | 28 | $308 |
| PFIZER INC. | 22 | $256 |
| Lilly USA, LLC | 4 | $186 |
| ARGENX US, INC. | 6 | $186 |
| AstraZeneca Pharmaceuticals LP | 5 | $178 |
| Eisai Inc. | 14 | $157 |
| Impel Pharmaceuticals LLC | 4 | $79 |
| Alnylam Pharmaceuticals Inc. | 4 | $73 |
Products named: KESIMPTA, NURTEC ODT, QULIPTA, BOTOX, KISUNLA, AUSTEDO XR, AJOVY, Leqembi.
Industry payments across NJ — which companies pay providers there.
